Skip to main content
Top
Published in: BMC Geriatrics 1/2019

Open Access 01-12-2019 | Antibiotic | Research article

Risk factors for vancomycin-resistant enterococcus acquisition during a large outbreak in patients aged 65 years and older

Authors: Benjamin Mathis, Max Haïne, Raphaële Girard, Marc Bonnefoy

Published in: BMC Geriatrics | Issue 1/2019

Login to get access

Abstract

Background

In the context of an aging population, identifying risk factors for Vancomycin-resistant enterococci (VRE), specific to older people, is important. However, if age is a known risk factor for VRE infection, a limited number of studies have focused on older patients. This study aimed to identify potential risk factors for VRE acquisition in a population aged 65 years and older, during a large VRE outbreak that occurred in a teaching hospital in Lyon, France, from December 2013 to July 2014.

Methods

The present retrospective, multi-center, descriptive, and analytical study used part of a previous cohort, and included only a sub-group of patients aged 65 years and older. The analysis of the factors included in the original study was completed with factors more specific to geriatric patients. Inclusion criteria were patients aged 65 years and older, in contact with a VRE index patient. Patients were screened by rectal swabs. Univariate and multivariate logistic regression analyses were performed.

Results

A total of 180 VRE contacts were included and 18 patients became carriers. Multivariate analysis showed that risk factors for VRE acquisition in older people included major contact type (RR: 5.31, 95%CI [1.33; 21.19]), number of antibiotics used (RR: 1.36, 95%CI [1.04; 1.76]), a score of McCabe = 2 (RR: 116.39, 95%CI [5.52; 2455.98]), ethylism (RR: 5.50, 95%CI [1.49; 20.25]), and dementia (RR: 7.50, 95%CI [1.89; 29.80]).

Conclusions

This study was able to demonstrate risk factors for VRE acquisition in older people. These risk factors should be taken into account when in the presence of older people in a VRE infected unit.
Literature
6.
go back to reference Elizaga ML, Weinstein RA, Hayden MK. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis. 2002;34:441–6.CrossRef Elizaga ML, Weinstein RA, Hayden MK. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis. 2002;34:441–6.CrossRef
8.
go back to reference Tan D, Htun HL, Koh J, Kanagasabai K, Lim J-W, Hon P-Y, et al. Comparative epidemiology of Vancomycin-resistant enterococci colonization in an acute-care hospital and its affiliated intermediate- and long-term care facilities in Singapore. Antimicrob Agents Chemother. 2018;62. Tan D, Htun HL, Koh J, Kanagasabai K, Lim J-W, Hon P-Y, et al. Comparative epidemiology of Vancomycin-resistant enterococci colonization in an acute-care hospital and its affiliated intermediate- and long-term care facilities in Singapore. Antimicrob Agents Chemother. 2018;62.
9.
go back to reference William R, McCabe, Jackson GG. Gram-negative bacteremia: I. etiology and ecology. Arch Intern Med. 1962;110:847–55.CrossRef William R, McCabe, Jackson GG. Gram-negative bacteremia: I. etiology and ecology. Arch Intern Med. 1962;110:847–55.CrossRef
10.
11.
go back to reference Monteserin N, Larson E. Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. J Hosp Infect. 2016;94:236–41.CrossRef Monteserin N, Larson E. Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. J Hosp Infect. 2016;94:236–41.CrossRef
12.
go back to reference Moemen D, Tawfeek D, Badawy W. Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University hospitals intensive care units, Egypt. Braz J Microbiol Publ Braz Soc Microbiol. 2015;46:777–83.CrossRef Moemen D, Tawfeek D, Badawy W. Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University hospitals intensive care units, Egypt. Braz J Microbiol Publ Braz Soc Microbiol. 2015;46:777–83.CrossRef
13.
go back to reference Beltrami EM, Singer DA, Fish L, Manning K, Young S, Banerjee SN, et al. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control. 2000;28:282–5.CrossRef Beltrami EM, Singer DA, Fish L, Manning K, Young S, Banerjee SN, et al. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control. 2000;28:282–5.CrossRef
14.
go back to reference De Decker L. L’indice de co-morbidité de Charlson. Ann Gérontologie. 2009;2:159–60. De Decker L. L’indice de co-morbidité de Charlson. Ann Gérontologie. 2009;2:159–60.
15.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.CrossRef Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.CrossRef
16.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRef
19.
go back to reference Kim J-M, Shin I-S, Stewart R, Yoon J-S. Alcoholism in older Korean men: prevalence, aetiology, and comorbidity with cognitive impairment and dementia in urban and rural communities. Int J Geriatr Psychiatry. 2002;17:821–7.CrossRef Kim J-M, Shin I-S, Stewart R, Yoon J-S. Alcoholism in older Korean men: prevalence, aetiology, and comorbidity with cognitive impairment and dementia in urban and rural communities. Int J Geriatr Psychiatry. 2002;17:821–7.CrossRef
20.
go back to reference Thomas VS, Rockwood KJ. Alcohol abuse, cognitive impairment, and mortality among older people. J Am Geriatr Soc. 2001;49:415–20.CrossRef Thomas VS, Rockwood KJ. Alcohol abuse, cognitive impairment, and mortality among older people. J Am Geriatr Soc. 2001;49:415–20.CrossRef
21.
go back to reference Mitchell SL, Shaffer ML, Loeb MB, Givens JL, Habtemariam D, Kiely DK, et al. Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia. JAMA Intern Med. 2014;174(10):1660–7.CrossRef Mitchell SL, Shaffer ML, Loeb MB, Givens JL, Habtemariam D, Kiely DK, et al. Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia. JAMA Intern Med. 2014;174(10):1660–7.CrossRef
22.
go back to reference Shorman M, Al-Tawfiq JA. Risk factors associated with vancomycin-resistant enterococcus in intensive care unit settings in Saudi Arabia. Interdiscip Perspect Infect Dis. 2013;2013:369674.CrossRef Shorman M, Al-Tawfiq JA. Risk factors associated with vancomycin-resistant enterococcus in intensive care unit settings in Saudi Arabia. Interdiscip Perspect Infect Dis. 2013;2013:369674.CrossRef
23.
go back to reference Kee SY, Park CW, Lee JE, Kwon YJ, Pyo HJ, Western Dialysis Physical Association, et al. Healthcare-associated risk factors of vancomycin-resistant enterococci colonization among outpatients undergoing hemodialysis. Jpn J Infect Dis. 2012;65:57–60.PubMed Kee SY, Park CW, Lee JE, Kwon YJ, Pyo HJ, Western Dialysis Physical Association, et al. Healthcare-associated risk factors of vancomycin-resistant enterococci colonization among outpatients undergoing hemodialysis. Jpn J Infect Dis. 2012;65:57–60.PubMed
24.
go back to reference Zacharioudakis IM, Zervou FN, Ziakas PD, Rice LB, Mylonakis E. Vancomycin-resistant enterococci colonization among Dialysis patients: a meta-analysis of prevalence, risk factors, and significance. Am J Kidney Dis. 2015;65:88–97.CrossRef Zacharioudakis IM, Zervou FN, Ziakas PD, Rice LB, Mylonakis E. Vancomycin-resistant enterococci colonization among Dialysis patients: a meta-analysis of prevalence, risk factors, and significance. Am J Kidney Dis. 2015;65:88–97.CrossRef
25.
go back to reference McEvoy SP, Plant AJ, Pearman JW, Christiansen KJ. Risk factors for the acquisition of vancomycin-resistant enterococci during a single-strain outbreak at a major Australian teaching hospital. J Hosp Infect. 2006;62:256–8.CrossRef McEvoy SP, Plant AJ, Pearman JW, Christiansen KJ. Risk factors for the acquisition of vancomycin-resistant enterococci during a single-strain outbreak at a major Australian teaching hospital. J Hosp Infect. 2006;62:256–8.CrossRef
26.
go back to reference Warren DK, Nitin A, Hill C, Fraser VJ, Kollef MH. Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2004;25:99–104.CrossRef Warren DK, Nitin A, Hill C, Fraser VJ, Kollef MH. Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2004;25:99–104.CrossRef
28.
go back to reference Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, et al. Prior environmental contamination increases the risk of Acquisition of Vancomycin-Resistant Enterococci. Clin Infect Dis. 2008;46:678–85.CrossRef Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, et al. Prior environmental contamination increases the risk of Acquisition of Vancomycin-Resistant Enterococci. Clin Infect Dis. 2008;46:678–85.CrossRef
Metadata
Title
Risk factors for vancomycin-resistant enterococcus acquisition during a large outbreak in patients aged 65 years and older
Authors
Benjamin Mathis
Max Haïne
Raphaële Girard
Marc Bonnefoy
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2019
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-019-1398-2

Other articles of this Issue 1/2019

BMC Geriatrics 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.